ISRCTN ISRCTN11899548
DOI https://doi.org/10.1186/ISRCTN11899548
Secondary identifying numbers 5 RO1 NR007787-02
Submission date
20/05/2004
Registration date
28/07/2004
Last edited
31/07/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Mary Ersek
Scientific

550 16th Ave
Suite 405
Seattle
98122
United States of America

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeQuality of life
Scientific title
Study acronymPSM Study
Study objectivesThe primary goal of this study is to evaluate the efficacy of a pain self-management group intervention (SMG), as compared with a control condition (BOOK), in decreasing physical disability, pain, pain-related interference with activities, and depression in older retirement community residents with chronic pain. The hypotheses are as follows:
1. At post-treatment and each follow-up, participants assigned to SMG, as compared with participants assigned to BOOK, will report less physical disability (primary outcome), and lower pain intensity, pain-related interference with activities, and depressive symptom severity (secondary outcomes)
2. Participants assigned to SMG, as compared with participants assigned to BOOK, will show greater pre- to post-treatment increases in self-efficacy and use of adaptive pain coping strategies and greater decreases in catastrophizing. Significant differences between SMG and BOOK groups in pain-related beliefs and coping strategies will be maintained at 6-month and 1-year follow-ups.
3. Pre- to post-treatment changes in specific pain-related beliefs (catastrophizing, self-efficacy) and coping strategies (Chronic Pain Coping Inventory subscales) will be associated significantly with changes in physical and social functioning, pain intensity, and depression over the same period among SMG participants. These changes in beliefs and coping strategies will be maintained at 6-month and 1-year follow-ups.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedChronic pain
InterventionAfter all participants from a facility have completed the baseline questionnaires, the facility is randomised to receive either the BOOK or the SMG.

SMG intervention:
This consists of seven weekly 90-minute group sessions. The SMG group facilitator telephones each participant at 12, 16, 22, and 30 weeks after the final group session. During the booster phone calls, facilitators inquire about pain and functioning, current pain management plans, and successes and obstacles in meeting pain management goals, as well as provide encouragement and assistance in problem-solving obstacles encountered in pain management.

BOOK intervention:
Participants receive a copy of The Chronic Pain Workbook, 2nd Edition. Facilitators telephone participants 1 and 4 weeks after participants receive the workbook. BOOK participants receive follow-up phone calls at the same intervals to control for attention.
Intervention typeOther
Primary outcome measureRoland-Morris Disability Questionnaire (RMDQ)
Secondary outcome measures1. Brief Pain Inventory (BPI)
2. Geriatric Depression Scale (GDS)
Overall study start date01/01/2004
Completion date01/01/2005

Eligibility

Participant type(s)Patient
Age groupSenior
SexBoth
Target number of participants273
Key inclusion criteria1. Adults 65 years or older
2. Non-cancer musculoskeletal pain greater than three months duration that interferes with daily activities
3. Can read and comprehend questionnaires in English
4. No or minimal cognitive impairment
5. Have not had surgery within the past six months
6. Do not have surgery planned in the next six months
Key exclusion criteriaCurrent, active cancer
Date of first enrolment01/01/2004
Date of final enrolment01/01/2005

Locations

Countries of recruitment

  • United States of America

Study participating centre

550 16th Ave
Seattle
98122
United States of America

Sponsor information

NIH/National Institute of Nursing Research (USA)
Government

Bldg. 45, Rm 3AN12
45 Center Drive
MSC 6300
Bethesda
20892-6300
United States of America

ROR logo "ROR" https://ror.org/01y3zfr79

Funders

Funder type

Government

National Institutes of Health (NIH) (USA) (ref: 5 RO1 NR007787-02)
Government organisation / National government
Alternative name(s)
Institutos Nacionales de la Salud, US National Institutes of Health, NIH
Location
United States of America

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article Protocol 30/07/2004 Yes No
Results article Descriptive study results 08/11/2005 Yes No
Results article RCT results 15/08/2008 Yes No